Oct. 12, 2023, 4:27 p.m. | Ron Miller

TechCrunch techcrunch.com

Israeli biotech startup Mana.bio has been planning to launch its programmable drug treatment solution for months, and decided to forge ahead in spite of the attacks that happened this past weekend in the country. The company is using an AI-driven approach called liquid nanoparticles (LNP) to create unique programmable drug treatments. “Mana.bio’s integrated experimental and […]

ai drug discovery attacks bio biotech biotech & health country israeli startups launch mana.bio planning solution startup startups therapy treatment

Lead Developer (AI)

@ Cere Network | San Francisco, US

Research Engineer

@ Allora Labs | Remote

Ecosystem Manager

@ Allora Labs | Remote

Founding AI Engineer, Agents

@ Occam AI | New York

AI Engineer Intern, Agents

@ Occam AI | US

AI Research Scientist

@ Vara | Berlin, Germany and Remote